Glaxosmithkline transfer pricing law in Canada clarified for cross - border investors Lorne H. Saltman
By: Saltman, Lorne H
.
Material type: 
ArticlePublisher: 2011Subject(s): PRECIOS DE TRANSFERENCIA | IMPUESTOS | ESTADOS UNIDOS
In:
Journal of Taxation of Investments v. 28, n. 2, Winter 2011, p. 61-71
| Item type | Current location | Home library | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| IEF | OP 235/2011/28/2-4 (Browse shelf) | Available | OP 235/2011/28/2-4 |
Browsing IEF Shelves Close shelf browser
| No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
| OP 235/2011/28/2-1 Tax issues for real estate investors considering a mortgage defeasance as part of a Section 1031 Exchange | OP 235/2011/28/2-2 Personal goodwill | OP 235/2011/28/2-3 Changes to U.S. taxation of foreign income | OP 235/2011/28/2-4 Glaxosmithkline | OP 235/2011/28/2-5 Reaching potential | OP 235/2011/28/3-1 The past, present and future of equity swaps | OP 235/2011/28/3-2 Changes to income and excise taxation of mutual funds under the Regulated Investment Company Modernization Act of 2010 |
Resumen. Conclusión.
There are no comments for this item.